02- Mar- 2023: Mindray India is delighted to announce that Mr. Steven Mou, has been appointed as the new Managing Director of Mindray India effective 01 Jan 2023. He has more than 15 years of experience in sales, marketing, and business development. He is responsible for overall Sales & Marketing and general management of Mindray India. He shares Mindray India’s achievements and its future strategies to be a trusted partner in building a healthier Bharat.
Mindray strongly believes in innovation ever since it was founded. We have never stopped our pace to explore the latest technology and new ideas. We have strong global R&D, where we adopt advanced technologies and transform them into accessible innovation, bringing healthcare within reach.
We are grateful for the support of our customers, partners, and well-wishers, because of whom Mindray has been growing strong in the last decade. We have established a leading position in many segments like ultrasound, patient monitoring, hematology, anesthesia, etc.
Our products like Resona I9, an innovative ultrasound imaging system, powered by ZST technology, with an intelligent control panel, and infinite imaging solutions was able to break barriers and create waves in the ultrasound field. Our smart ICU, M-Connect revolutionized IT solutions by offering holistic and timely solutions.
Mindray’s new MC-80 is taking digital morphology analysis to the next level, delivering clearer images which are able to capture abnormalities in more detail. We plan to offer such total solutions in the future that addresses the needs of healthcare providers so that they can provide better services to their patients.
The growth rate of Mindray in India has been incredible. We have a sound network of sales, distribution, and service across India that intends to provide stability to the company and boost the development of its products. The size of our employees has grown too, five times more than that was five years ago. Our employees are the face of our organization, and we ensure that we keep them motivated and content. We aim to create sustainable workplaces that help not only in the growth of our employees but also helps in delivering the latest innovations to the hinterlands of India.
Mindray has also been hosting several workshops and knowledge-sharing sessions that enabled the healthcare givers to deliver their best and made us their trusted partner for building a healthier Bharat.
We hope to expand our growth in India by exploring opportunities to advance new technology, adapting new management styles, and exchanging new thoughts. We will also uphold the concept of sustainability, deepen, and broaden our collaboration, and strengthen the integration of corporate strategy and social responsibility, to keep up with the development of the times and the needs of the industry.
Being an important player in the global healthcare industry, we believe in delivering reliable and easy-to-use solutions so that healthcare professionals can focus on patients. We look forward to transforming the healthcare sector in India by providing advanced medical technologies while reducing costs and making healthcare accessible to all.
This press release is published by VOH team.*
Psoriasis drug launch marks Eli Lilly’s entry into dermatology domain
SAMRIDH Healthcare invests in Critical Care Hope to catalyze tele-ICUs across th
Health Check on Wheels: Apollo Hospitals Launches Gujarat’s First Fully-equipp
Steven Mou to steer Mindray’s ‘India Mission’ as Managing Director
Making Robotics Mainstream: HCG Hospitals Collaborates with Us-Based Intuitive t
Dr. Rajeev Singh Raghuvanshi appointed Drugs Controller General of India
Accurex BGMS (Blood Glucose Monitoring System) Factory Inauguration at Andhra Pr
VOH: Incubator Driving Innovation and Improving Access to Healthcare in India
Augnito Launches Its Developer Portal To Abridge Integration Timelines
MediBuddy acquires ‘vHealth by Aetna’, the India health business of Aetna In
Ayurveda in MBBS Curriculum?
The First Active Bone Conduction Implant (Bone Bridge - BCI-602) in India was do
UPSC recommends Rajeev Singh Raghuvanshi as next DCGI
Mankind Pharma invests in Actimed Therapeutics, a UK based clinical stage specia
Tata Capital Healthcare Fund infuses $ 10 mn in Mumbai Oncocare CentreView All